Gregory T. Went
2018
In 2018, Gregory T. Went earned a total compensation of $3.4M as Chief Executive Officer at Adamas Pharmaceuticals, a 20% increase compared to previous year.
Compensation breakdown
| Bonus | $260,200 |
|---|---|
| Option Awards | $2,013,363 |
| Salary | $550,000 |
| Stock Awards | $529,238 |
| Other | $6,322 |
| Total | $3,359,123 |
Went received $2M in option awards, accounting for 60% of the total pay in 2018.
Went also received $260.2K in bonus, $550K in salary, $529.2K in stock awards and $6.3K in other compensation.
Rankings
In 2018, Gregory T. Went's compensation ranked 3,407th out of 14,244 executives tracked by ExecPay. In other words, Went earned more than 76.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,407 out of 14,244 | 76th |
Division Manufacturing | 1,260 out of 5,758 | 78th |
Major group Chemicals And Allied Products | 440 out of 2,119 | 79th |
Industry group Drugs | 362 out of 1,808 | 80th |
Industry Pharmaceutical Preparations | 278 out of 1,382 | 80th |
Source: SEC filing on April 25, 2019.
Went's colleagues
We found three more compensation records of executives who worked with Gregory T. Went at Adamas Pharmaceuticals in 2018.